(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Pick Your Number one Sort Of Music - 2Sean Penn lights up, Kylie Jenner gets A-list approval and 7 other moments you didn’t see at the Golden Globes
- 3Flu cases are rising with a strain that makes older people sicker
- 4This Tiny Neon Frog Dwells in the Clouds
- 5A Russian fighting for Ukraine conned the Kremlin out of $500,000 by faking his own death
- Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
- Well known Tea Brands for Each Tea Sweetheart
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- Rick Steves Prefers Paying A Bit Extra For This Delectable Food When Dining In Spain
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Figuring out the Business venture Code: The Response to Building an Effective Startup
- The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior
- Exclusive-Head of Pemex's production arm to step down in coming days, sources say
